Your trusted source for investing success

Tag: research

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization team.
Mr. Manuele is a results-oriented, innovative executive with thirty-five years of comprehensive US and International expertise in nuclear medicine and medical isotope production. A long-time veteran of Amersham Health and

ConforMIS Gets FDA Approval for iTotal Hip System

ConforMIS (NASDAQ:CFMS) has announced the receipt of FDA 510(k) clearance for its primary iTotal hip replacement system.

As quoted in the news article:
The ConforMIS iTotal Hip system features proprietary iFit image-to-implant technology. The system utilizes the company’s patient-specific technology and single-use 3D printed instruments. The iTotal Hip system is expected to

Honey Badger Exploration Announces Acquisition of Zinc and Barite Assets in Quebec, Financing and Share Consolidation

TORONTO, ONTARIO–(Marketwired – June 26, 2017) – Honey Badger Exploration Inc. (TSX VENTURE:TUF) (“Honey Badger” or the “Company”) has entered into an agreement, subject to certain terms and conditions, to acquire three (3) assets located in Québec (the “Mineral Properties”). The three properties – the Upton Property, the Saint-Fabien Property,

eGain announces embedded AI knowledge for Cisco Finesse™ desktop

eGain (NASDAQ:EGAN) has announced eGain Solve for Cisco, a cloud-based solution integrated with Cisco’s contact center platform and as part of the Cisco SolutionsPlus program.

As quoted in the press release:
eGain Solve™ for Cisco allows voice and digital contact center agents on Cisco Finesse to confidently answer customer questions by clicking

Global Cannabis Appoints Managing Director for Australia

Global Cannabis Appoints Managing Director for Australia

Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, is pleased to announce it has established a presence in Australia with the appointment of Jason Webb as Managing Director for Australian Operations.

Jason Webb has extensive experience in tech commercialisation in

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced it has received Institutional Review Board (IRB) approval to conduct its pivotal Phase 3 Study in Temozolomide-Avastin (bevacizumab) Recurrent GBM (STAR-3).

“IRB approval is an essential step in initiating patient enrollment in our

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network